Although there was no significant difference compared with HIs in the GSE19147 dataset, the proportion of TCF1+CD3+ T cells in CLL patients displayed a clear downward trend (P = 0.098; Figure 2B). The gene discussed is TCF7; the disease is B-cell chronic lymphocytic leukemia.